Indoco Remedies Limited
NSE: INDOCO BSE: INDOCO
NSE
226.93
2.56 (1.14%)
Prev Close
224.37
Open Price
212.65
Volume
228,598
Today Low / High
212.65 / 232
52 WK Low / High
190 / 387.55
Range
216 - 238
BSE
225.50
-0.25 (-0.11%)
Prev Close
225.75
Open Price
215.15
Volume
8,759
Today Low / High
212 / 231.4
52 WK Low / High
190 / 385.5
Range
214 - 237
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 226.93 (target range: 216 - 238), reflecting a change of 2.56 (1.14097%). On the BSE, it is listed at 225.5 (target range: 214 - 237), showing a change of -0.25 (-0.11074%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
04 Mar
212.65
6.80%
03 Mar
199.40
12.52%
28 Feb
200.00
-1.77%
27 Feb
212.00
-5.64%
25 Feb
221.36
-5.69%
24 Feb
233.90
-4.39%
21 Feb
233.00
0.47%
20 Feb
243.50
-4.87%
19 Feb
244.39
-1.53%
18 Feb
247.80
-1.38%
17 Feb
246.00
1.78%
14 Feb
252.00
-2.42%
13 Feb
258.08
-2.94%
12 Feb
256.00
0.81%
11 Feb
263.65
-2.25%
10 Feb
280.24
-5.21%
07 Feb
282.00
-0.62%
06 Feb
278.87
0.29%
05 Feb
264.00
4.60%
04 Feb
259.00
1.78%
Indoco Remedies Limited Graph
Indoco Remedies Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking Target Price for Indoco Remedies Limited T1, T2, T3, for both Bullish or Bearish. For Bullish T1, T2, T3 and for Bearish T1, T2, T3. The stock current price is 227, with potential price targets ranging from T1, T2, T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 225.50 | 227.76 | 204.98 - 250.53 |
| 230.01 | 184.01 - 276.01 | ||
| 232.27 | 162.59 - 301.94 | ||
| Bearish Scenario | 225.50 | 223.25 | 200.92 - 245.57 |
| 220.99 | 176.79 - 265.19 | ||
| 218.74 | 153.11 - 284.36 |
Overview of Indoco Remedies Limited
ISIN
INE873D01024
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
139,287
Market Cap
20,861,862,585
Last Dividend
1.5
Official Website
IPO Date
2005-01-14
DCF Diff
497.78
DCF
-247
Financial Ratios Every Investor Needs
Stock Dividend of INDOCO
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2024-09-19 | September 19, 24 | 1.5 | 1.5 | 2024-09-19 | 2024-10-26 | |
| 2023-09-18 | September 18, 23 | 2.25 | 2.25 | 2023-09-19 | 2023-10-26 | |
| 2022-09-14 | September 14, 22 | 0.75 | 0.75 | 2022-09-15 | 2022-10-22 | |
| 2021-09-17 | September 17, 21 | 1.5 | 1.5 | 2021-09-20 | 2021-10-23 | |
| 2020-09-18 | September 18, 20 | 0.3 | 0.3 | 2020-09-21 | 2020-10-24 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 1,788.22 Cr | 1,185.32 Cr | 602.90 Cr | 0.3372 | 97.16 Cr | 36.76 Cr | 152.44 Cr | 98.46 Cr | 10.51 | 264.71 Cr | 0.0551 |
| 2023-03-31 | 1,640.05 Cr | 521.29 Cr | 1,118.76 Cr | 0.6821 | 80.97 Cr | 264.68 Cr | 217.83 Cr | 142.25 Cr | 15.44 | 288.18 Cr | 0.0867 |
| 2022-03-31 | 1,503.74 Cr | 463.77 Cr | 1,039.97 Cr | 0.6916 | 74.64 Cr | 12.51 Cr | 255.33 Cr | 154.80 Cr | 16.80 | 324.63 Cr | 0.1029 |
| 2021-03-31 | 1,218.61 Cr | 359.64 Cr | 858.97 Cr | 0.7049 | 59.70 Cr | 16.73 Cr | 168.14 Cr | 93.05 Cr | 10.10 | 227.22 Cr | 0.0764 |
| 2020-03-31 | 1,079.98 Cr | 335.07 Cr | 744.91 Cr | 0.6897 | 49.70 Cr | 29.55 Cr | 61.91 Cr | 24.12 Cr | 2.62 | 120.15 Cr | 0.0223 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 14.86 Cr | 2,144.73 Cr | 1,034.23 Cr | 1,109.9001 Cr | 671.95 Cr | 657.10 Cr | 372.06 Cr | 979.28 Cr | 7.61 Cr | 0.00 Cr | -4.12 Cr | 612.3300 Cr |
| 2023-03-31 | 10.93 Cr | 1,658.20 Cr | 629.95 Cr | 1,028.2500 Cr | 332.85 Cr | 321.92 Cr | 325.99 Cr | 667.59 Cr | 13.06 Cr | 0.00 Cr | -2.99 Cr | 424.5100 Cr |
| 2022-03-31 | 17.47 Cr | 1,486.09 Cr | 581.45 Cr | 904.6401 Cr | 256.67 Cr | 239.20 Cr | 310.52 Cr | 584.66 Cr | 3.72 Cr | 0.00 Cr | -24.60 Cr | 424.8536 Cr |
| 2021-03-31 | 9.42 Cr | 1,315.06 Cr | 546.07 Cr | 768.9906 Cr | 266.74 Cr | 257.32 Cr | 237.85 Cr | 553.53 Cr | 54.78 Cr | -42.16 Cr | -2.08 Cr | 406.9199 Cr |
| 2020-03-31 | 23.76 Cr | 1,271.60 Cr | 592.03 Cr | 679.5694 Cr | 268.81 Cr | 245.05 Cr | 208.32 Cr | 548.95 Cr | 63.79 Cr | -42.17 Cr | -2.98 Cr | 458.9864 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 156.6982 Cr | -433.8300 Cr | 280.4346 Cr | -270.6049 Cr | 3.9253 Cr | 14.8557 Cr | -427.3031 Cr | 124.2707 Cr | 340.3342 Cr | -20.7059 Cr | -27.0800 Cr |
| 2023-03-31 | 178.8200 Cr | -208.1800 Cr | 22.8100 Cr | -28.4300 Cr | -6.5400 Cr | 10.9300 Cr | -207.2500 Cr | 192.7900 Cr | 72.4957 Cr | -20.7211 Cr | -15.4700 Cr |
| 2022-03-31 | 173.8287 Cr | -121.4082 Cr | -44.3720 Cr | 48.5052 Cr | 8.0485 Cr | 17.4662 Cr | -125.3235 Cr | 236.5712 Cr | -14.3053 Cr | -13.7932 Cr | -72.6647 Cr |
| 2021-03-31 | 82.2220 Cr | -66.6933 Cr | -29.8731 Cr | 5.3731 Cr | -14.3444 Cr | 9.4177 Cr | -76.8489 Cr | 131.9971 Cr | -3.0878 Cr | -2.7887 Cr | -29.5343 Cr |
| 2020-03-31 | 122.8477 Cr | -55.9330 Cr | -63.9494 Cr | 64.3833 Cr | 2.9653 Cr | 23.7621 Cr | -58.4644 Cr | 28.5723 Cr | -38.1798 Cr | -3.3632 Cr | -24.8660 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 402.45 Cr | 113.92 Cr | 288.53 Cr | 0.7169 | 0.00 Cr | -26.39 Cr | -3.08 | 13.87 Cr | -0.0656 |
| 2024-09-30 | 432.66 Cr | 258.50 Cr | 174.16 Cr | 0.4025 | 11.43 Cr | -9.57 Cr | -1.04 | 41.81 Cr | -0.0221 |
| 2024-06-30 | 431.49 Cr | 266.27 Cr | 165.22 Cr | 0.3829 | 20.25 Cr | 2.62 Cr | 0.28 | 48.80 Cr | 0.0061 |
| 2024-03-31 | 449.64 Cr | 255.41 Cr | 194.23 Cr | 0.4320 | 22.64 Cr | 22.70 Cr | 2.39 | 71.26 Cr | 0.0505 |
| 2023-12-31 | 458.75 Cr | 142.32 Cr | 316.43 Cr | 0.6898 | 40.90 Cr | 16.30 Cr | 1.77 | 57.05 Cr | 0.0355 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 18.18 Cr | 26.32 Cr | 44.50 Cr | 383.42 Cr | 382.72 Cr | 1,034.74 Cr | 1,026.78 Cr | 2,389.83 Cr | 1,300.96 Cr |
| 2024-06-30 | -31.57 Cr | 63.14 Cr | 31.57 Cr | 0.00 Cr | 0.00 Cr | 31.57 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 24.33 Cr | 7.24 Cr | 31.57 Cr | 434.47 Cr | 353.06 Cr | 954.67 Cr | 891.09 Cr | 2,144.73 Cr | 1,034.23 Cr |
| 2023-12-31 | -68.25 Cr | 136.50 Cr | 68.25 Cr | 0.00 Cr | 0.00 Cr | 68.25 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 61.02 Cr | 22.23 Cr | 83.25 Cr | 0.00 Cr | 355.43 Cr | 997.56 Cr | 705.95 Cr | 1,938.04 Cr | 867.69 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 2.62 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 22.70 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 16.30 Cr | 48.70 Cr | 0.00 Cr | 0.00 Cr | 48.70 Cr | 113.88 Cr | 65.18 Cr | 0.00 Cr | 48.70 Cr |
| 2023-09-30 | 35.08 Cr | 42.82 Cr | 0.00 Cr | 0.00 Cr | 42.82 Cr | 65.18 Cr | 22.36 Cr | 0.00 Cr | 42.82 Cr |
| 2023-06-30 | 24.39 Cr | 39.76 Cr | 0.00 Cr | 0.00 Cr | 39.76 Cr | 53.11 Cr | 13.35 Cr | 0.00 Cr | 39.76 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2012-05-17 | May 17, 12 | 5:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,558.65 | ₹3,739,637,772,000.00 | ₹781,719.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹5,506.25 | ₹1,461,738,681,250.00 | ₹64,908.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹2,949.60 | ₹998,277,372,000.00 | ₹166,276.00 |
| Mankind Pharma Limited | MANKIND | ₹2,291.25 | ₹945,320,533,950.00 | ₹177,711.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,114.75 | ₹928,700,476,795.00 | ₹434,095.00 |
| Lupin Limited | LUPIN | ₹1,934.60 | ₹883,108,142,600.00 | ₹259,741.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹870.20 | ₹875,621,346,000.00 | ₹343,556.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,050.85 | ₹610,335,781,700.00 | ₹413,280.00 |
| Alkem Laboratories Limited | ALKEM | ₹4,591.20 | ₹548,946,828,000.00 | ₹17,608.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,313.55 | ₹370,668,047,400.00 | ₹97,865.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,339.40 | ₹339,811,137,600.00 | ₹56,310.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,451.70 | ₹306,246,750,400.00 | ₹61,223.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,161.90 | ₹295,779,073,500.00 | ₹165,600.00 |
| Laurus Labs Limited | LAURUSLABS | ₹541.60 | ₹292,059,424,800.00 | ₹1,255,902.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,614.85 | ₹251,280,349,100.00 | ₹29,467.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,238.20 | ₹201,165,401,200.00 | ₹280,998.00 |
| Piramal Enterprises Limited | PEL | ₹877.00 | ₹197,744,206,000.00 | ₹172,994.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹7,180.00 | ₹179,500,000,000.00 | ₹18,235.00 |
| Eris Lifesciences Limited | ERIS | ₹1,181.00 | ₹160,768,349,000.00 | ₹22,410.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹775.65 | ₹152,464,090,950.00 | ₹312,147.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹917.85 | ₹146,196,065,850.00 | ₹70,165.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹11,307.10 | ₹145,068,962,290.00 | ₹40,103.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹801.90 | ₹143,628,309,000.00 | ₹553,341.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,794.05 | ₹136,368,790,385.00 | ₹351,707.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹474.45 | ₹115,051,278,300.00 | ₹761,172.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,120.00 | ₹84,988,928,000.00 | ₹2,119.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹733.60 | ₹66,483,240,936.00 | ₹180,483.00 |
| FDC Limited | FDC | ₹380.40 | ₹61,932,924,000.00 | ₹76,550.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹623.30 | ₹60,953,067,970.00 | ₹158,952.00 |
| Strides Pharma Science Limited | STAR | ₹606.80 | ₹55,924,326,360.00 | ₹175,466.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹912.85 | ₹46,298,930,435.00 | ₹61,199.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹630.35 | ₹44,380,296,030.00 | ₹15,929.00 |
| Hikal Limited | HIKAL | ₹353.10 | ₹43,537,583,100.00 | ₹104,019.00 |
| Innova Captab Limited | INNOVACAP | ₹676.60 | ₹38,718,387,638.00 | ₹65,536.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹117.03 | ₹37,978,809,660.00 | ₹840,880.00 |
| Sequent Scientific Limited | SEQUENT | ₹145.38 | ₹36,388,904,760.00 | ₹484,563.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,080.00 | ₹34,401,120,000.00 | ₹13,355.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹316.20 | ₹31,707,903,600.00 | ₹60,257.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹346.80 | ₹31,652,436,000.00 | ₹50,219.00 |
| Suven Life Sciences Limited | SUVEN | ₹116.15 | ₹25,329,295,100.00 | ₹387,876.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹45.64 | ₹25,008,620,560.00 | ₹2,413,022.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹469.75 | ₹23,648,166,244.00 | ₹100,544.00 |
| Alembic Limited | ALEMBICLTD | ₹89.77 | ₹23,051,320,050.00 | ₹318,318.00 |
| Indoco Remedies Limited | INDOCO | ₹226.93 | ₹20,933,815,947.00 | ₹228,598.00 |
| Bajaj HealthCare Limited | BAJAJHCARE | ₹635.05 | ₹20,056,974,665.00 | ₹289,638.00 |
Key Executives
Chief Marketing Officer
Mr. Rajesh Usgaonker
Gender: male
Year Born:
Non-Executive Chairman & Whole time Director
Mr. Suresh Govind Kare
Gender: male
Year Born: 1939
MD & Executive Director
Ms. Aditi Milind Panandikar
Gender: female
Year Born: 1970
Head of OSD
Mr. Prashant Pathak
Gender: male
Year Born:
Joint MD & Executive Director
Mr. Sundeep Vasant Bambolkar
Gender: male
Year Born: 1960
President of Sales & Marketing
Mr. Ajay Karajagi
Gender: male
Year Born:
GM of Legal, Company Secretary & Compliance Officer
Mr. Ramanathan Hariharan
Gender: male
Year Born:
Vice President of Corporate HR
Mr. Rajan B Saawant
Gender: male
Year Born:
Chief Financial Officer
Mr. Pramod Ghorpade
Gender: male
Year Born:
Chief Technical Officer
Dr. Kavita Inamdar
Gender: Not Specified
Year Born: 1967
FAQs about Indoco Remedies Limited
Who is the CEO of the company?
The CEO is Mr. Suresh Govind Kare.
What is the current market price of the stock?
The current price is ₹226.15.
What is the 52-week price range?
The range is ₹190-387.55.
What is the market capitalization of the company?
The market capitalization is ₹2,086.19 crores.
What is the dividend yield?
The dividend yield is 0.66%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is -182.11.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Indoco Remedies Limited (ISIN: INE873D01024) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹2,086.19 crores and an average daily volume of 139,287 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹1.5.